Giulia De Rossi is a Senior Research Fellow at the Institute of Ophthalmology, University College London (UCL). After spending one year at the DKFZ in Heidelberg during her MSc (funded by an
Erasmus scholarship), she came to London to join the centre for microvascular research at QMUL led by Professor Sussan Nourshargh, where she earned a Ph.D. in 2016. Here, under the supervision of Dr James Whiteford, she studied the roles and effects of the syndecan family of heparan-sulphate proteoglycans on angiogenesis and endothelial cell biology. In 2019, she joined the UCL Institute of Ophthalmology, driven by a growing interest in retinal vascular diseases. Her project in the lab of Professors Steve Moss and John Greenwood aimed to pin down the role of the protein LRG1 (leucine-rich alpha-2-glycoprotein 1) in the early steps of diabetic retinopathy (DR). In 2023, she was awarded an RD Lawrence Fellowship co-funded by Diabetes UK and Moorfields Eye Charity, during which she aims to characterize the cellular and molecular landscape of the early vascular changes happening in the human and murine diabetic retina.
Giulia De Rossi is a Senior Research Fellow at the Institute of Ophthalmology, University College London (UCL). After spending one year at the DKFZ in Heidelberg during her MSc (funded by an
Erasmus scholarship), she came to London to join the centre for microvascular research at QMUL led by Professor Sussan Nourshargh, where she earned a Ph.D. in 2016. Here, under the supervision of Dr James Whiteford, she studied the roles and effects of the syndecan family of heparan-sulphate proteoglycans on angiogenesis and endothelial cell biology. In 2019, she joined the UCL Institute of Ophthalmology, driven by a growing interest in retinal vascular diseases. Her project in the lab of Professors Steve Moss and John Greenwood aimed to pin down the role of the protein LRG1 (leucine-rich alpha-2-glycoprotein 1) in the early steps of diabetic retinopathy (DR). In 2023, she was awarded an RD Lawrence Fellowship co-funded by Diabetes UK and Moorfields Eye Charity, during which she aims to characterize the cellular and molecular landscape of the early vascular changes happening in the human and murine diabetic retina.